1952.HK
Price:
$47
Market Cap:
$15.00B
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.
Industry
Biotechnology
IPO Date
2020-10-09
Stock Exchange
HKSE
Ticker
1952.HK
According to Everest Medicines Limited’s latest financial reports and current stock price. The company's current ROE is -16.47%. This represents a change of 301.64% compared to the average of -4.10% of the last 4 quarters.
The mean historical ROE of Everest Medicines Limited over the last ten years is -2.86%. The current -16.47% ROE has changed 476.69% with respect to the historical average. Over the past ten years (40 quarters), 1952.HK's ROE was at its highest in in the June 2020 quarter at 168.67%. The ROE was at its lowest in in the March 2020 quarter at -55.28%.
Average
-2.86%
Median
-17.00%
Minimum
-83.06%
Maximum
104.65%
Discovering the peaks and valleys of Everest Medicines Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 288.63%
Maximum Annual ROE = 104.65%
Minimum Annual Increase = -469.66%
Minimum Annual ROE = -83.06%
| Year | ROE | Change |
|---|---|---|
| 2024 | -25.57% | 50.44% |
| 2023 | -17.00% | 288.63% |
| 2022 | -4.37% | -74.46% |
| 2021 | -17.12% | -79.39% |
| 2020 | -83.06% | -469.66% |
| 2019 | 22.47% | -78.53% |
The current ROE of Everest Medicines Limited (1952.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-15.65%
5-year avg
-29.42%
10-year avg
-2.86%
Everest Medicines Limited’s ROE is greater than Keymed Biosciences Inc. (-9.08%), greater than Guangzhou Innogen Pharmaceutl Grp Co Ltd (-31.88%), greater than Zai Lab Limited (-27.32%), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (3.43%), less than Nanjing Leads Biolabs Co Ltd (0%), greater than CStone Pharmaceuticals (-71.29%), greater than InnoCare Pharma Limited (-3.39%), greater than CARsgen Therapeutics Holdings Limited (-39.53%), greater than CanSino Biologics Inc. (-2.87%), greater than Ascentage Pharma Group International (-249.24%),
| Company | ROE | Market cap |
|---|---|---|
| -9.08% | $16.03B | |
| -31.88% | $14.64B | |
| -27.32% | $15.11B | |
| 3.43% | $16.94B | |
| 0% | $9.61B | |
| -71.29% | $8.62B | |
| -3.39% | $19.43B | |
| -39.53% | $8.30B | |
| -2.87% | $12.69B | |
| -249.24% | $20.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Everest Medicines Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Everest Medicines Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Everest Medicines Limited's ROE?
How is the ROE calculated for Everest Medicines Limited (1952.HK)?
What is the highest ROE for Everest Medicines Limited (1952.HK)?
What is the 3-year average ROE for Everest Medicines Limited (1952.HK)?
What is the 5-year average ROE for Everest Medicines Limited (1952.HK)?
How does the current ROE for Everest Medicines Limited (1952.HK) compare to its historical average?